首页> 美国卫生研究院文献>PLoS Biology >Sugar industry sponsorship of germ-free rodent studies linking sucrose to hyperlipidemia and cancer: An historical analysis of internal documents
【2h】

Sugar industry sponsorship of germ-free rodent studies linking sucrose to hyperlipidemia and cancer: An historical analysis of internal documents

机译:制糖业赞助的无糖啮齿动物研究将蔗糖与高脂血症和癌症联系起来:内部文献的历史分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In 1965, the Sugar Research Foundation (SRF) secretly funded a review in the New England Journal of Medicine that discounted evidence linking sucrose consumption to blood lipid levels and hence coronary heart disease (CHD). SRF subsequently funded animal research to evaluate sucrose’s CHD risks. The objective of this study was to examine the planning, funding, and internal evaluation of an SRF-funded research project titled “Project 259: Dietary Carbohydrate and Blood Lipids in Germ-Free Rats,” led by Dr. W.F.R. Pover at the University of Birmingham, Birmingham, United Kingdom, between 1967 and 1971. A narrative case study method was used to assess SRF Project 259 from 1967 to 1971 based on sugar industry internal documents. Project 259 found a statistically significant decrease in serum triglycerides in germ-free rats fed a high sugar diet compared to conventional rats fed a basic PRM diet (a pelleted diet containing cereal meals, soybean meals, whitefish meal, and dried yeast, fortified with a balanced vitamin supplement and trace element mixture). The results suggested to SRF that gut microbiota have a causal role in carbohydrate-induced hypertriglyceridemia. A study comparing conventional rats fed a high-sugar diet to those fed a high-starch diet suggested that sucrose consumption might be associated with elevated levels of beta-glucuronidase, an enzyme previously associated with bladder cancer in humans. SRF terminated Project 259 without publishing the results. The sugar industry did not disclose evidence of harm from animal studies that would have (1) strengthened the case that the CHD risk of sucrose is greater than starch and (2) caused sucrose to be scrutinized as a potential carcinogen. The influence of the gut microbiota in the differential effects of sucrose and starch on blood lipids, as well as the influence of carbohydrate quality on beta-glucuronidase and cancer activity, deserve further scrutiny.
机译:1965年,糖研究基金会(SRF)秘密资助了《新英格兰医学杂志》上的一篇评论,该评论驳斥了将蔗糖消耗与血脂水平以及冠心病(CHD)相关的证据。 SRF随后资助了动物研究,以评估蔗糖的冠心病风险。这项研究的目的是检查由SRF资助的W.F.R.博士领导的研究项目“项目259:无胚芽的饮食中的碳水化合物和血脂”的计划,经费和内部评估。 1967年至1971年间,在英国伯明翰的伯明翰大学任教。根据叙事案例研究方法,根据制糖业内部文件评估了1967年至1971年的SRF项目259。项目259发现,饲喂高糖饮食的无菌大鼠的血清甘油三酯与饲喂基本PRM饮食的常规大鼠(含谷粉,大豆粉,白鱼粉和干酵母的颗粒饮食,经强化的谷氨酸强化)相比,统计学上显着降低。平衡的维生素补充剂和微量元素的混合物)。结果提示SRF,肠道菌群在碳水化合物诱导的高甘油三酯血症中具有因果作用。一项将高糖饮食与高淀粉饮食的常规大鼠进行比较的研究表明,蔗糖的摄入可能与β-葡萄糖醛酸苷酶(一种以前与人类膀胱癌相关的酶)水平升高有关。 SRF终止了项目259,但未发布结果。制糖业没有公开动物研究的危害证据,这会(1)加强蔗糖的冠心病风险大于淀粉的风险,(2)将蔗糖作为潜在的致癌物进行审查。肠微生物群对蔗糖和淀粉对血脂的不同作用的影响,以及碳水化合物质量对β-葡萄糖醛酸苷酶和癌症活性的影响,值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号